Advertisement Fidelity
Home > Boards > US Listed > Biotechs >


Add BNIKF Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator Wildbilly, Blane
Search This Board:
Last Post: 4/21/2014 10:26:27 PM - Followers: 29 - Board type: Free - Posts Today: 0
Silencing Genes For Life™

ddRNAi: expressed RNA interference technology
ddRNAi (DNA-directed RNAi) is a unique platform technology for silencing unwanted or disease-causing genes. In the context of therapy, ddRNAi avoids many of the drawbacks of other gene silencing technologies and produces much longer-lasting effects. Benitec Biopharma pioneered ddRNAi and was the first company to demonstrate expressed RNAi in human cells. We hold a dominant intellectual property position in RNAi, with over 40 issued global patents for the human use of ddRNAi. Learn how ddRNAi could target countless human and viral genes. Track our pipeline programs using this exciting technology. View the scope of our patents in ddRNAi. Join us in developing transformational solutions for human health.

Pipeline for ddRNAi gene silencing

Benitec Biopharma’s pipeline of in-house and partnered programs to develop therapeutics for chronic and life-threatening conditions is based on our proprietary technology, DNA-directed RNA(ddRNAi). View our out-licensed programs  

Due to its demonstrated ability to effect long-lasting gene silencing, once proven in human trials, ddRNAi technology has significant potential to treat or cure a broad range of human diseases and conditions. These include cancers, neurological diseases, infectious diseases, autoimmune diseases, genetic diseases and other afflictions that are associated with the expression of a small number of key genes.

Our in-house pipeline is summarized below,  In-house pipeline


. View our out-licensed programs  Out-licensed programs Successful development of therapeutic products in just one of these programs would be a major breakthrough in medical therapy.




Expressed RNAi for lasting treatment or cure

Tacere Therapeutics develops human therapeutics based on RNA interference (RNAi)  and ddRNAi gene-silencing technology from Benitec Biopharma. Using this approach, the drugs we create promise long term treatment or cure with a single dose.

We target human diseases for which there is currently no effective treatment.  Our pipeline includes drugs for Hepatitis C and Age-Related Macular Degeneration.

Tacere Therapeutics is a Benitec Biopharma company.


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
#360  Sticky Note Benitec Info/Due Diligence Consolidated 3-30-2014 Blane 03/30/14 11:00:52 PM
#451   TT-034 georgejjl 04/21/14 10:26:27 PM
#450   You might not get that low, my friend. Blane 04/21/14 08:25:56 PM
#449   I'm guessing more red...I'm going to wait for RS Development 04/21/14 08:01:09 AM
#448   The latest video regarding Benitec georgejjl 04/20/14 08:37:08 AM
#447   Happy Easter!!! georgejjl 04/20/14 07:41:21 AM
#446   Gene Silencing georgejjl 04/19/14 08:42:22 PM
#445   Calimmune licensed ddRNAi technology from Benitec georgejjl 04/19/14 05:28:35 PM
#444   I feel ya! I rolled one of Blane 04/19/14 12:36:11 AM
#443   Baller, haha...I'm playing small bets, $500 - $2000. RS Development 04/19/14 12:33:28 AM
#442   Cool. I bought at .57, and sold Blane 04/19/14 12:26:32 AM
#441   I bought at .85, sold at 1.30 on RS Development 04/19/14 12:24:51 AM
#440   Yeah, I actually had a convo with someone Blane 04/19/14 12:09:29 AM
#439   I agree...This tech is revolutionary, I just feel RS Development 04/18/14 11:38:15 PM
#438   Yeah, but the longs like us know that Blane 04/18/14 10:25:18 PM
#437   4-17-14 Total Vol 150.7K 68-Tele 04/18/14 06:47:12 PM
#436   This has been getting shorted big time. RS Development 04/18/14 08:38:28 AM
#435   Yeah, I think the delay is just the Blane 04/17/14 09:47:52 PM
#434   Thanks Blane. I'm starting to believe that this Rh1968 04/17/14 06:59:03 PM
#433 Blane 04/17/14 12:28:47 PM
#431   I did! Got another 2k shares! Blane 04/16/14 07:07:46 PM
#430   What do you think guys? RS Development 04/16/14 07:49:00 AM
#428   Wednesday April 16 in Australia georgejjl 04/15/14 10:22:17 PM
#427   I think it may be at the close Blane 04/15/14 08:12:06 PM
#426 Go Rh1968 04/15/14 07:45:38 PM
#425   So when Benitec announces the first patient has Rh1968 04/15/14 06:13:41 PM
#424   I hope this price holds until the end RS Development 04/15/14 03:45:52 PM
#423   Benitec Biopharma Completes AUD $31.5 million Private Placement Minding 04/15/14 10:40:48 AM
#422   Novartis pulled out of RNAi 68-Tele 04/15/14 04:27:03 AM
#421   Rh, if you look at this guy's profile, Blane 04/15/14 02:36:39 AM
#420   Instead of posting the link, it would be Blane 04/15/14 02:21:26 AM
#419   Today's News georgejjl 04/14/14 11:15:52 PM
#418   From the Austrailian market: georgejjl 04/14/14 11:11:28 PM
#417   What in the hell does that mean? Rh1968 04/14/14 10:40:15 PM
#416   Benitec halted in Australia, according to timmuggs 04/14/14 10:27:48 PM
#415   Seeking Alpha georgejjl 04/14/14 08:41:05 PM
#414   Novartis and Benitec georgejjl 04/14/14 08:28:50 PM
#413   You also have to remember that the patient Rh1968 04/14/14 06:39:25 PM
#412   Do you think if Benitec would provide full 68-Tele 04/14/14 06:20:30 PM
#411 NEW4THIS 04/14/14 08:21:41 AM
#410   It was, which is also interesting that you Blane 04/13/14 04:33:40 PM
#409   I'm pretty sure I read that TT-034 was Rh1968 04/13/14 04:26:11 PM
#408   Nice article. According to the abstract of Blane 04/13/14 04:12:57 PM
#407   "dosing is eminent" NEW4THIS 04/13/14 03:40:24 PM
#406   Yeah, really. I wish it were that Blane 04/11/14 10:06:14 PM
#405   I know a way the first dosing will Rh1968 04/11/14 08:47:46 PM
#404   Like I said before, my opinion is that Blane 04/11/14 05:51:09 PM
#403   Yeah, looking at the clinical trials dot gov Blane 04/10/14 11:34:55 AM
#402   Results from the meeting georgejjl 04/10/14 03:45:36 AM
#401   Thanks for the info. I'm sure this funding Awchiro 04/10/14 01:58:12 AM
#400   Looks like we may have to wait a Rh1968 04/09/14 08:54:40 PM